Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

49.11
+1.453.04%
Post-market: 47.70-1.4100-2.87%18:48 EST
Volume:1.06M
Turnover:52.16M
Market Cap:3.00B
PE:-38.66
High:50.17
Open:47.62
Low:47.62
Close:47.66
52wk High:51.00
52wk Low:23.30
Shares:61.15M
Float Shares:59.26M
Volume Ratio:0.69
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2703
EPS(LYR):-1.2987
ROE:-16.79%
ROA:-13.49%
PB:6.58
PE(LYR):-37.82

Loading ...

Is Twist’s Expanded NGS Library Kit Portfolio and Higher 2026 Guidance Altering The Investment Case For Twist Bioscience (TWST)?

Simply Wall St.
·
Yesterday

Twist Bioscience Officer Dennis Cho Reports Sale of Common Shares

Reuters
·
Feb 14

Twist Bioscience stellt neue Library-Preparation-Kits für präzisere Genomsequenzierung vor

Reuters
·
Feb 10

Twist Bioscience Corporation Held Shareholder Meeting

Reuters
·
Feb 07

Twist Bioscience Raises Outlook As AI DNA Demand Builds Profit Focus

Simply Wall St.
·
Feb 04

Twist Bioscience Is Maintained at Overweight by Barclays

Dow Jones
·
Feb 03

Twist Bioscience vergibt neue Aktienanreizpakete an 52 neue Mitarbeiter

Reuters
·
Feb 03

Twist Bioscience Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Feb 03

Twist Bioscience : Barclays Raises Target Price to $50 From $39

THOMSON REUTERS
·
Feb 03

Twist Bioscience price target raised to $50 from $39 at Barclays

TIPRANKS
·
Feb 03

Why Is Twist Bioscience Stock Soaring Monday?

Benzinga
·
Feb 03

Twist Bioscience rises 12.5%

TIPRANKS
·
Feb 02

Stock Track | Twist Bioscience Soars 9.02% on Strong Q1 Results and Raised Guidance

Stock Track
·
Feb 02

Sector Update: Health Care

MT Newswires Live
·
Feb 02

Shares of Twist Bioscience up 7.6% Premarket After Co Forecasts Q2 Revenue Forecast Above Estimates

THOMSON REUTERS
·
Feb 02

Stock Track | Twist Bioscience Soars 7.38% in Pre-market on Strong Q1 Results and Upbeat Guidance

Stock Track
·
Feb 02

Rpt-Twist Bioscience Corp Outlook Q2 Total Revenue of Approximately $107 Million to $108 Million

THOMSON REUTERS
·
Feb 02

Twist Bioscience reports Q1 revenue of USD 103.7 million, up 17%

Reuters
·
Feb 02

GUIDANCE: (TWST) Twist Bioscience Expects Fiscal 2026 Total Revenue Range $435M to $440M, vs. FactSet Est of $432.3M

MT Newswires Live
·
Feb 02

Twist Bioscience Q1 EPS USD -0.5

THOMSON REUTERS
·
Feb 02